Douglas D. Richman, MD
Distinguished Professor of Pathology and Medicine
Departments of Pathology and Medicine
University of California San Diego
Veterans Affairs San Diego Healthcare System
San Diego, CA

University Web site link: http://cfar.ucsd.edu/about-us/directors-biography

Research, Lecture, and Writing Topics

• HIV drug resistance and evolution
• HIV primary infection
• HIV therapy and pathogenesis
• The latent reservoir and eradication

Current Professional Summary

Dr Richman is Distinguished Professor of Pathology and Medicine at the University of California San Diego. He is Director of the Center for AIDS Research and the AIDS Research Institute at UCSD. In addition, he holds the Florence Seeley Riford Chair for AIDS Research. Dr Richman is a founding member of the Board of Directors of the IAS–USA and Editor-in-Chief of Topics in Antiviral Medicine.

Committees and Organizations

• Member, Board of Directors, IAS–USA
• Member, Antiretroviral Guidelines Panel, IAS–USA
• Member, Resistance Testing Guidelines Panel, IAS–USA
• Conference on Retroviruses and Opportunistic Infections Program Committee
• International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies
• Institute of Medicine and National Academy of Science’s Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008

Honors and Awards

• Alpha Omega Alpha, Stanford University (1970)
• Lowell Rantz Award in Infectious Diseases, Stanford University (1970)
• AMA Physicians Recognition Award (1976, 1979, 1982)
• Fellow of the John Simon Guggenheim Foundation (1984–1985)
• Visiting Fellowship, Clare Hall, University of Cambridge (1984–1985)
• Howard Temin Award for Clinical Sciences for Scientific Excellence in the Fight Against HIV/AIDS (1993)
• Dept of Veterans Affairs William S. Middleton Award, 2002
• Pan American Society for Clinical Virology: Clinical Virology Award, 2004
• Bernard Fields Memorial Lectureship, 15th Conference on Retroviruses and Opportunistic Infections, 3 February 2008
• Docteur en Medecine, Honoris Causa, University of Lausanne, 2010

Education

• Dartmouth College, AB Cum Laude (1965)
• Stanford University, MD (1970)
• Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Disease, Postdoctoral (1972–1975)
• Beth Israel and Children's Hospital, Boston, Postdoctoral (1975–1976)

Selected Publications

1. Larder B, Darby G, Richman DD. HIV with reduced sensitivty to zidovudine isolated during prolonged therapy. Science. 1989;243:1731-1734.
2. Richman DD, Havlir D, Corbeil J, et al. Nevirapine resistance mutations of HIV-1 selected during therapy. J Virol. 1994;68:1660-1666.
3. Wong JK, Hezareh M, Günthard H, Havlir DV, Ignacio CC, Spina CA, Richman DD. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291-1294.
4. Richman DD. HIV chemotherapy. Nature. 2001;410:995-1001.
5. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway, B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. Antiretroviral drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385-394.
6. Richman DD, Wrin TL, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA. 2003;100:4144-4149.
7. Richman DD, Morton SC, Wrin T, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS. 2004;18:1-7.
8. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD, Antiretroviral Drug Resistance in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel. Clin Infect Dis. 2008;47:266-285.
9. Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. 3rd ed. Washington, DC: ASM Press; 2009.
10. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of a cure for HIV infection. Science. 2009;323:1304-1307.
11. Thompson MA, Aberg JA, Cahn P, Montaner JSG, Rizzardini G, Telenti A, Gatell JM, Günthard H, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT. Antiretroviral Treatment of Adult HIV Infection: 2010 Recommendations of the International AIDS Society-USA Panel. JAMA. 2010;304(3): 321-333.

Return to Top